🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesMetabolic syndrome reversal — my 5 criteria all normalized Page 4

Metabolic syndrome reversal — my 5 criteria all normalized

steve_okc Wed, May 27, 2026 at 3:47 AM 20 replies 513 viewsPage 4 of 4
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
May 28, 2026 at 4:54 AM#16

From the other side of the consultation, briefly. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Correct me if the detail matters more than I have assumed.

10 10kevin_tulsa, Dr.PainCLE, mike_mealprep and 7 others
Reply Quote Save Share Report
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
May 28, 2026 at 7:58 AM#17
TirzTom said:
Practical: whatever you change, write down the date and the reason.

Coming at TirzTom’s question from a different direction. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

9 9julia.endo, JessicaM_2024, TomFromTexas and 6 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
May 28, 2026 at 11:02 AM#18

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

8 8DataDave, Dr.GutHealth, amsterdam_pete and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
May 28, 2026 at 2:06 PM#19

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

7 7AttorneyGrant, DebRD_ATL, KristenIndy and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 28, 2026 at 5:10 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

Last edited: May 28, 2026 at 9:10 PM
35 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 32 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register